Petersen MC, Shulman GI. Mechanisms of Insulin Action and Insulin Resistance. Physiol Rev. 2018;98(4):2133–223. https://doi.org/10.1152/physrev.00063.2017.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barber TM, Kyrou I, Randeva HS, Weickert MO. Mechanisms of Insulin Resistance at the Crossroad of Obesity with Associated Metabolic Abnormalities and Cognitive Dysfunction. Int J Mol Sci. 2021;22(2):546. https://doi.org/10.3390/ijms22020546.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park SE, Park CY, Sweeney G. Biomarkers of insulin sensitivity and insulin resistance: Past, present and future. Crit Rev Clin Lab Sci. 2015;52(4):180–90. https://doi.org/10.3109/10408363.2015.1023429.

Article  CAS  PubMed  Google Scholar 

Burhans MS, Hagman DK, Kuzma JN, Schmidt KA, Kratz M. Contribution of Adipose Tissue Inflammation to the Development of Type 2 Diabetes Mellitus. Compr Physiol. 2018;9(1):1–58. https://doi.org/10.1002/cphy.c170040.

Article  PubMed  PubMed Central  Google Scholar 

Rohm TV, Meier DT, Olefsky JM, Donath MY. Inflammation in obesity, diabetes, and related disorders. Immunity. 2022;55(1):31–55. https://doi.org/10.1016/j.immuni.2021.12.013.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haeusler RA, Mcgraw TE, Accili D. Biochemical and cellular properties of insulin receptor signalling. Nat Rev Mol Cell Biol. 2018;19(1):31–44. https://doi.org/10.1038/nrm.2017.89.

Article  CAS  PubMed  Google Scholar 

Yamauchi T, Kadowaki T. Adiponectin Receptor as a Key Player in Healthy Longevity and Obesity-Related Diseases. Cell Metab. 2013;17(2):185–96. https://doi.org/10.1016/j.cmet.2013.01.001.

Article  CAS  PubMed  Google Scholar 

James DE, Stockli J, Birnbaum MJ. The aetiology and molecular landscape of insulin resistance. Nat Rev Mol Cell Biol. 2021;22(11):751–71. https://doi.org/10.1038/s41580-021-00390-6.

Article  CAS  PubMed  Google Scholar 

King DE, Mainous AG, Buchanan TA, Pearson WS. C-Reactive Protein and Glycemic Control in Adults With Diabetes. Diabetes Care. 2003;26(5):1535–9. https://doi.org/10.2337/diacare.26.5.1535.

Article  PubMed  Google Scholar 

Golubnitschaja O, Baban B, Boniolo G, Wang W, Bubnov R, Kapalla M, Krapfenbauer K, Mozaffari MS, Costigliola V. Medicine in the early twenty-first century: paradigm and anticipation-EPMA position paper 2016. EPMA J. 2016;7(1). https://doi.org/10.1186/s13167-016-0072-4.

Smokovski I, Steinle N, Behnke A, Bhaskar SMM, Grech G, Richter K, et al. Digital biomarkers: 3PM approach revolutionizing chronic disease management — EPMA 2024 position. EPMA J. 2024;15(2):149–62. https://doi.org/10.1007/s13167-024-00364-6.

Article  PubMed  PubMed Central  Google Scholar 

Xiao Y, Xiao X, Zhang X, Yi D, Li T, Hao Q, et al. Mediterranean diet in the targeted prevention and personalized treatment of chronic diseases: evidence, potential mechanisms, and prospects. EPMA J. 2024;15(2):207–20. https://doi.org/10.1007/s13167-024-00360-w.

Article  PubMed  Google Scholar 

Koklesova L, Mazurakova A, Samec M, Biringer K, Samuel SM, Busselberg D, et al. Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person. EPMA J. 2021;12(4):477–505. https://doi.org/10.1007/s13167-021-00263-0.

Article  PubMed  PubMed Central  Google Scholar 

Kropp M, Golubnitschaja O, Mazurakova A, Koklesova L, Sargheini N, Vo TKS, et al. Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications-risks and mitigation. EPMA J. 2023;14(1):21–42. https://doi.org/10.1007/s13167-023-00314-8.

Article  PubMed  PubMed Central  Google Scholar 

Qian S, Golubnitschaja O, Zhan X. Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles. EPMA J. 2019;10(4):365–81. https://doi.org/10.1007/s13167-019-00194-x.

Article  PubMed  PubMed Central  Google Scholar 

Sena CM, Goncalves L, Seica R. Methods to evaluate vascular function: a crucial approach towards predictive, preventive, and personalised medicine. EPMA J. 2022;13(2):209–35. https://doi.org/10.1007/s13167-022-00280-7.

Article  PubMed  PubMed Central  Google Scholar 

Wang W. Glycomedicine: The Current State of the Art. Engineering. 2023;26:12–5. https://doi.org/10.1016/j.eng.2022.03.009.

Article  CAS  Google Scholar 

Meng X, Wang F, Gao X, Wang B, Xu X, Wang Y, et al. Association of IgG N-glycomics with prevalent and incident type 2 diabetes mellitus from the paradigm of predictive, preventive, and personalized medicine standpoint. EPMA J. 2023;14(1):1–20. https://doi.org/10.1007/s13167-022-00311-3.

Article  PubMed  Google Scholar 

Yu L, Wan Q, Liu Q, Fan Y, Zhou Q, Skowronski AA, et al. IgG is an aging factor that drives adipose tissue fibrosis and metabolic decline. Cell Metab. 2024;36(4):793–807.e5. https://doi.org/10.1016/j.cmet.2024.01.015.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Walters H. IgG is an early driver of aging. Nature Aging. 2024;4(3):279–279. https://doi.org/10.1038/s43587-024-00602-6.

Article  PubMed  Google Scholar 

Wang TT, Ravetch JV. Functional diversification of IgGs through Fc glycosylation. J Clin Investig. 2019;129(9):3492–8. https://doi.org/10.1172/jci130029.

Article  PubMed  PubMed Central  Google Scholar 

Adua E, Anto EO, Roberts P, Kantanka OS, Aboagye E, Wang W. The potential of N-glycosylation profiles as biomarkers for monitoring the progression of Type II diabetes mellitus towards diabetic kidney disease. J Diabetes Metab Disord. 2018;17(2):233–46. https://doi.org/10.1007/s40200-018-0365-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Plomp R, Ruhaak LR, Uh HW, Reiding KR, Selman M, Houwing-Duistermaat JJ, Slagboom PE, Beekman M, Wuhrer M. Subclass-specific IgG glycosylation is associated with markers of inflammation and metabolic health. Sci Rep. 2017;7(1). https://doi.org/10.1038/s41598-017-12495-0.

Memarian E, Heijmans R, Slieker RC, Sierra A, Gornik O, Beulens JWJ, et al. IgG N-glycans are associated with prevalent and incident complications of type 2 diabetes. Diabetes Metab Res Rev. 2023;39(7): e3685. https://doi.org/10.1002/dmrr.3685.

Article  CAS  PubMed  Google Scholar 

Gu Y, Duan B, Sha J, Zhang R, Fan J, Xu X, et al. Serum IgG N-glycans enable early detection and early relapse prediction of colorectal cancer. Int J Cancer. 2023;152(3):536–47. https://doi.org/10.1002/ijc.34298.

Article  CAS  PubMed  Google Scholar 

Kristic J, Lauc G. The importance of IgG glycosylation-What did we learn after analyzing over 100,000 individuals. Immunol Rev. 2024;328(1):143–70. https://doi.org/10.1111/imr.13407.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pezer M. Immunoglobulin G Glycosylation in Diseases.In Antibody Glycosylation. 2021, Springer International Publishing: Cham. p. 395–431. https://doi.org/10.1007/978-3-030-76912-3_13.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9. https://doi.org/10.1007/bf00280883.

Article  CAS  PubMed  Google Scholar 

Diniz M, Beleigoli AMR, Schmidt MI, Duncan BB, Ribeiro ALP, Vidigal PG, et al. Homeostasis model assessment of insulin resistance (HOMA-IR) and metabolic syndrome at baseline of a multicentric Brazilian cohort: ELSA-Brasil study. Cad Saude Publica. 2020;36(8): e00072120. https://doi.org/10.1590/0102-311X00072120.

Article  PubMed  Google Scholar 

Huang R, Cheng Z, Jin X, Yu X, Yu J, Guo Y, et al. Usefulness of four surrogate indexes of insulin resistance in middle-aged population in Hefei. China Annals of Medicine. 2022;54(1):622–32. https://doi.org/10.1080/07853890.2022.2039956.

Article  CAS